Browsing Centre for Clinical Pharmacology by Subject "Cost-Benefit Analysis"
Now showing items 1-1 of 1
-
Potential economic consequences of a cardioprotective agent for patients with myocardial infarction: modelling study.
(2015-11-13)OBJECTIVE: To investigate the cost-effectiveness of a hypothetical cardioprotective agent used to reduce infarct size in patients undergoing percutaneous coronary intervention (PCI) after anterior ST-elevation myocardial ...